Bio: Alan Mertz is Director of Government Relations for NeoGenomics Laboratories, one of the nation’s leading oncology diagnostic and pharma services laboratories. He has more than 30 years of experience in government, leading healthcare trade associations, and advising laboratories on reimbursement and regulatory issues.
From 2003 to 2017, Mertz was President of the American Clinical Laboratory Association (ACLA), where he led the clinical laboratory industry’s advocacy efforts on critical reimbursement and regulatory issues. During his tenure, ACLA’s membership, visibility, and advocacy effectiveness grew exponentially. Among ACLA’s advocacy successes during his tenure were stopping three proposals to impose coinsurance for laboratory services in Medicare, repealing a misguided Medicare “competitive bidding” project, and defeating a new federal excise tax on all laboratory reimbursement. In addition, Mertz led ACLA’s 13-year successful effort to hold off the FDA’s proposals to regulate Laboratory Developed Tests.
Prior to joining ACLA, Mertz was Executive Vice President and Acting President of the Healthcare Leadership Council, and for 17 years served in three senior staff positions in the United States House of Representatives and the United States Senate.